Filing Details
- Accession Number:
- 0001571049-15-010402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-30 21:01:16
- Reporting Period:
- 2015-12-28
- Filing Date:
- 2015-12-30
- Accepted Time:
- 2015-12-30 21:01:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601607 | Bfi Co., Llc | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2015-12-28 | 12,000 | $0.00 | 78,000 | No | 4 | C | Direct | |
Class A Common Stock | Disposition | 2015-12-28 | 4,000 | $30.34 | 74,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2015-12-29 | 4,000 | $30.49 | 70,000 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2015-12-30 | 4,000 | $30.63 | 66,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Class B Common Stock | Disposition | 2015-12-28 | 12,000 | $0.00 | 12,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,959,811 | No | 4 | C | Direct |
Footnotes
- The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.97 to $30.88, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.08 to $30.75, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.40 to $30.85, inclusive.